International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Europe 2024

Short Course

Sunday 17 November | 08:00 – 12:00 (CET)

Health Economic Modeling in R: A Hands-on Introduction
Lamrock F, Thom H, Baio G, Hart R

Issue Panel

Wednesday 20 November | 08:00 – 09:00 (CET)

Changing with the Times: Keeping up with Advancements in Comparative Efficacy Techniques While Maintaining the Path of HTA Informativeness
Moderator: Roiz J
Panellists: Westley T, Cooper M, AI M

Posters

Monday, 18 November – Poster Session 1 | 10:30 – 13:30 (CET)

Economic Burden of Charcot-Marie-Tooth Disease: A Systematic Review
Mahapatra S, Praveen N, Telukuntla V, Khurana I

Exploring PICO Variations in Relapsed or Refractory DLBCL in the Context of the European Joint Clinical Assessment
Jindal S, Paranjoy S

Impact on Health Outcomes and Productive Work of Anti-Pd-(L)1 Inhibitors to Treat Early-Stage Cancers in England
Burton H , Greenall S, Tan YZ, Neves C, Aguiar-Ibanez R

A Retrospective Analysis of the Healthcare Pathway of Head & Neck Cancer Patients From First Visit to a General Practitioner to Diagnosis in the Netherlands
Reimes N, Post J, Bailey S, Willems S, Kuiper J, Doornebos C, Overbeek J, Takes R

Monday, 18 November – Poster Session 2 | 16:00 – 19:00 (CET)

Health-Related Quality of Life of Individuals with Charcot-Marie-Tooth Disease: A Systematic Review
Mahapatra S, Praveen N, Telukuntla V, Khurana I, Ahuja A

Cost and Healthcare Resource Utilization (HRU) Among Patients Living with Angelman Syndrome (AS): A Systematic Review
Vyshnavi Telukuntla, Inderpreet Khurana, Rishabh Verma, Nidhun Praveen, Sukannya Mahapatra

Evaluating Efficacy and Safety of RNA Therapies Lumasiran and Nedosiran in Patients with Primary Hyperoxaluria Type 1 – A Systematic Literature Review
Gupta A, Mahajan K, Jindal S, Sharma A, Saharia P

Population Impact of Performing HRR Testing for Metastatic Castration-Resistant Prostate Cancer Treatment in the US
Bjerke A, Patterson B, Zielinkski M, Su N, Thompson A, Meng Y

Incorporating Patient Perspectives in Rare Disease Drug Development and HTA
Aidarous A, Malottki K, Browne C, Chapman AM

Interpreting the Non-Inferiority Evidence in NICE Streamlined Cost-Comparison Appraisals
Behr C, Guerra Primo L, Rupniewska E, Gladwell D, Matthijsse S

Systematic Review of Methimazole in Graves’ Disease Management: Treatment Variations and Efficacy Outcomes
Mahajan K, Sharma A, Jindal S, Gupta A, Saharia P

Cost of Managing Brain Metastases in Patients With ALK+ aNSCLC First-Line Tyrosine Kinase Inhibitors (TKIS) in Sweden
Nilsson F, Le H, Ladino D, Larsen MW

Considerations for Censoring Methods Used to Reconstruct Pseudo Patient-Level Data From Kaplan–Meier Curves: Does the Indirect Treatment Comparison Method Influence the Choice of Censoring Distribution?
Gulas I, Aiello E, Westley T

Factor Xa Inhibitor-Related Major Bleeding Events in the Netherlands
Smits E, Gaspersz J, Houben E, Penning-van Beest F, Cohen A, Mamza J, Beekman W, Houthuizen N, Leentjens J

Tuesday, 19 November – Poster Session 3 | 10:30 – 13:30 (CET)

Mixture Cure Model in HTA Submissions: A Comparative Review
Tan YZ, Smith M

Quality of Life and Its Drivers in Patients Living with Angelman Syndrome: A Systematic Review
Telukuntla V, Verma R, Kandoth N, Mahapatra S, Ahuja A, Khurana IS

Quality of Life and Its Drivers in Patients with Uveal Melanoma: A Systematic Review
Verma R, Telukuntla V, Khurana IS, Pillai S, Ahuja A

Assessing Trends in European Union’s Health Technology Assessment Submissions of Antibody-Drug Conjugates
Ghoshal D, Rohilla A, Madan T, Taneja A

Evaluating the Optimal Tki for Patients with ALK Positive Advanced Non-Small-Cell Lung Cancer (aNSCLC) in the First Line (1L) Setting: An Updated Systematic Literature Review (SLR) and Network Meta-Analysis (NMA)
Ou SH, Le H, Aiello E, Bradbury J, Ghoshal D, Taneja A, Kilvert H, Polli A, Rifi N, Zala D, Luan L, Zhu F, Han B.

The Economic Burden of Advanced/Metastatic Biliary Tract Cancer: A Systematic Literature Review
Valle J, Sabater J, Fan L, Bowditch S, Ahuja A, Paisley S, Gould I, Behr C, Greenall S, Su W, Dayyani F

Targeted Review: Generalizability of Clinical Trial Evidence to the Patient Population in NICE Technology Appraisals
Wijenayake N, Thornton I, Smith M

Economic Evaluation of Transcatheter Aortic Valve Implantation (TAVI) Relative to Other Interventions in Cardiovascular and Oncology Disease Areas: A Targeted Literature Review
Sarmah A, Candolfi P, Kearns B

Use of Qualitative In-Trial/Exit Interviews in Product Labelling and Health Technology Assessments
Johnson N, Weijers L, Egan S

Identifying and Profiling Patients With Heart Failure in a Population-Based Cohort Through Linkage of Primary and Secondary Care Data
Iob E, Heintjes E, Reimes N, Uijl A, Overbeek J, Herings RMC

Tuesday, 19 November – Poster Session 4 | 16:00 – 19:00 (CET)

Treatment Strategies for Uveal Melanoma – A Systematic Review
Verma R, Pillai S, Telukuntla V, Khurana IS, Ahuja A

Cost-Effectiveness Analysis of Osteosarcoma Treatment: Insights from a Systemic Literature Review
Donkana T, Garg J, Mandal A, Ahuja A

Group-Based Multivariate Trajectory Methods to Assess Patient-Reported Outcomes In Acute Myeloid Leukaemia: An Evaluation of Published Methods and Results
Aiello E, Gulas I, Westley T

Targeted Literature Review of in-Trial/Exit Interviews in Clinical Trials Focusing on Multiple Myeloma and Related Conditions
Cala ML, Cherepanov D, Vong K, Cureg B, Zhang S, Johnson N

Healthcare Resource Utilization Among Patients with Transfusion-Dependent Beta-Thalassemia in the Netherlands
Drahos J, Peres FS, Reimes N, van Pinxteren F, Overbeek J, Brown D, Li N

Wednesday, 20 November – Poster Session 4 | 09:00 – 11:30 (CET)

Systematic Review of Healthcare Costs and Resource Utilization in Fibromyalgia in European Countries and the US
Praveen N, Khurana IS, Mahapatra S, Telukuntla V, Ahuja A

Quality of Life in Early-Stage Chronic Kidney Disease: A Targeted Literature Review
Fotheringham J, Paisley S, Erickson K, Postma M, Bridges JFP, Boersma C, Ahuja A, Madan T, Verma R, Akehurst R, Winkelmayer W

The Benefits and Challenges of Streamlined NICE Cost Comparisons
Rupniewska E, Guerra Primo L, Behr C, Gladwell D, Matthijsse S

Exploring PICO Variations in the Context of the European Joint Clinical Assessment
Jindal S, Saharia P

Healthcare Resource Utilization Among Patients With Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the Netherlands
Drahos J, Peres FS, Reimes N, van Pinxteren F, Overbeek J,  Brown D, Li N